1. Electron microscopy and hydrogen-deuterium exchange establish the C1 domain as the major binding site for the VWF D'D3 domain on FVIII.
Introduction
The high-affinity, non-covalent association of factor VIII (FVIII) with von Willebrand factor (VWF) in the circulation protects FVIII from otherwise rapid clearance. 1 fragmentation and by analysis of naturally occurring type 2N VWD mutations. 5, 6 Consistent with these findings, recombinant D'D3 domains have been shown to be sufficient to elevate levels of endogenous FVIII in VWF-deficient mice. 7 The reciprocal binding site for VWF on FVIII was initially localized broadly to its light chain. 8 Subsequent studies demonstrated that the a3 acidic peptide region (E1649-R1689) 9 and a restricted fragment thereof (K1673-R1689) 10 , as well as sulfation on residue Y1680 within this region are important for VWF binding. 11 In addition, mutation analysis and antibody competition studies have implicated the C1 and C2 domains in VWF binding. 9, [12] [13] [14] [15] [16] To better understand the interaction between FVIII and VWF, we visualized FVIII-D'D3 complexes by electron microscopy (EM) and employed hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify structural perturbations in FVIII upon D'D3 binding. 
Results and Discussion

Electron microscopy of FVIII in complex with D'D3 domains
Negatively stained FVIII in complex with dimeric D'D3 showed substantial structural variability ( Figure 1A ), but many particles appeared to consist of two peripheral densities connected by a smaller central density (circled in Figure 1A ). Class averages ( Figure 1B and Figure S1 ) revealed the peripheral densities as FVIII, and thus the central, elongated density as the dimeric D'D3 (arrows in Figure 1B ). The angle between the two FVIII molecules varies dramatically (Video 1), and the dimeric D'D3 can also be positioned differently with respect to the two FVIII molecules. In panels 1 to 4 of Figure 1B , the long axis of the dimeric D'D3 is aligned with the two C domains of the FVIII on top (indicated by horizontal arrows), but only in some cases is it also aligned with the C domains of the second FVIII (panels 1 and 2 versus panels 3 and 4). In the remaining panels of Figure 1B , the long axis of the dimeric D'D3 is positioned either diagonally (panels 5 to 8) or perpendicular (panels 9 to 12) to the two C domains of the FVIII on top (indicated by the direction of the arrows).
To distinguish whether the observed heterogeneity resulted from structural variability of the two D'D3 domains in the dimeric construct or from different ways in which FVIII interacts with a D'D3 domain, we analyzed FVIII in complex with monomeric D'D3. The particles For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From appeared more homogeneous ( Figure 1C ), but class averages revealed that structural variability persisted ( Figure 1D and Figure S2 ). In particular, the density representing monomeric D'D3 (indicated by arrows) varies in shape and location relative to FVIII (Video 2). The difference in shape may be due to different orientations or due to partial loss of density upon averaging.
Importantly, while in some averages D'D3 appears to interact with both C domains of FVIII ( Figure 1D , panels 1 to 7), in other averages it appears to interact with only one C domain ( Figure 1D , panels 8 to 12). In the conventional orientation used to display FVIII, the molecule has the shape of a reversed "R", with the C1 domain at the bottom left of the molecule and the C2 domain at the bottom right ( Figure S3 ). Our averages thus suggested that the C1 domain is the primary binding site for D'D3 and that the C2 domain is a secondary binding site. To confirm this conclusion and to further characterize the interaction between D'D3 and FVIII, we performed HDX-MS.
Hydrogen-deuterium exchange mass spectrometry
Due to its ready availability and an affinity for VWF that is comparable to that of FVIII, pharmaceutical-grade rFVIIIFc was used for HDX-MS. 17 HDX-MS was performed with rFVIIIFc alone and in complex with monomeric D'D3. Stringent criteria were used to determine whether differential deuterium exchange was statistically significant: for a given peptide, the mass difference must exceed ± 0.5 Da for at least one time point and the sum of mass differences over all time points must exceed ± 1.1 Da 18 . Based on these criteria, ten distinct regions of differential deuterium exchange were initially identified within the FVIII component ( Figure   2A ). Region 1 was identified in the heavy chain of FVIII, within the A1 domain and encompassing residue C248, which forms a disulfide bond with C329. While differential
uptake at this site cannot be ruled out, given the distance from known VWF interaction sites, the observed mass difference ( Figure S4B , peptide 74) could be more readily rationalized by intramolecular hydrogen transfer upon generation of protein CysS• radicals during disulfide bond photolysis, as has been observed for immunoglobulins. 19 The remaining nine regions were located within the light chain: two in A3, five in C1, and two in C2. Each 
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